{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:18:31Z","timestamp":1726514311457},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.urology.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T15:17:25Z","timestamp":1484579845000},"page":"68-72","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The Impact of Baseline Functional Bladder Capacity on Short-term Neuromodulation Outcomes"],"prefix":"10.1016","volume":"102","author":[{"given":"Kim A.","family":"Killinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason P.","family":"Gilleran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Bartley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ehlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"Boura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.01.008_bib0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00192-010-1235-9","article-title":"Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation","volume":"22","author":"Marinkovic","year":"2011","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.urology.2017.01.008_bib0015","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/nau.20823","article-title":"Pudendal neuromodulation as a viable option for symptoms refractory to sacral neuromodulation","volume":"29","author":"Peters","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"5A suppl","key":"10.1016\/j.urology.2017.01.008_bib0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","article-title":"The interstitial cystitis symptom index and problem index","volume":"49","author":"O'Leary","year":"1997","journal-title":"Urology"},{"year":"2004","series-title":"An overactive bladder symptom and quality-of-life short form: development of the Overactive Bladder Questionnaire (OAB-q) short form (SF)","author":"Coyne","key":"10.1016\/j.urology.2017.01.008_bib0025"},{"key":"10.1016\/j.urology.2017.01.008_bib0030","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","article-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","volume":"178","author":"Van Kerrebroeck","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.008_bib0035","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.juro.2011.04.059","article-title":"Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60 women","volume":"186","author":"Groen","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.008_bib0040","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/01.ju.0000053863.96967.5a","article-title":"Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study","volume":"169","author":"Comiter","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.008_bib0045","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2012.11.175","article-title":"Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study","volume":"189","author":"Peters","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.008_bib0050","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.juro.2013.10.024","article-title":"Electrical stimulation of somatic afferent nerves in the foot increases bladder capacity in healthy human subjects","volume":"191","author":"Chen","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.01.008_bib0055","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1532-5415.2011.03492.x","article-title":"Prevalence and effect on health-related quality of life of overactive bladder in older Americans: results from the epidemiology of lower urinary tract symptoms study","volume":"59","author":"Sexton","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urology.2017.01.008_bib0060","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.urology.2010.08.039","article-title":"National community prevalence of overactive bladder in the United States stratified by sex and age","volume":"77","author":"Coyne","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.01.008_bib0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0090-4295(02)01841-1","article-title":"Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction","volume":"60","author":"Scheepens","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.01.008_bib0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/nau.22268","article-title":"Does patient age impact outcomes of neuromodulation?","volume":"32","author":"Peters","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.01.008_bib0075","article-title":"Sacral nerve neuromodulation in patients with underlying neurologic disease","volume":"197","author":"Wallace","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.urology.2017.01.008_bib0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ner.12109","article-title":"Predictors of implantable pulse generator placement after sacral neuromodulation: who does better?","volume":"17","author":"Anger","year":"2014","journal-title":"Neuromodulation"},{"key":"10.1016\/j.urology.2017.01.008_bib0085","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00192-011-1512-2","article-title":"Determining outcomes, adverse events, and predictors of success after sacral neuromodulation for lower urinary disorders in women","volume":"22","author":"Yazdany","year":"2011","journal-title":"Int Urogynecol J"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951730033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951730033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T01:33:38Z","timestamp":1620783218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951730033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":16,"alternative-id":["S009042951730033X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.01.008","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Baseline Functional Bladder Capacity on Short-term Neuromodulation Outcomes","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}